Global Healthcare Licensing Analytical Report 2019 with Focus on Genomics - ResearchAndMarkets.com

DUBLIN--()--The "Analytical Report for Healthcare Licensing with Focus on Genomics" report has been added to ResearchAndMarkets.com's offering.

260+ licensing news with a focus on Genomics is reported and analyzed to provide a snapshot view of the current business trends in this report.

Analytical data coverage:

  • January 1, 2019, to August 31, 2019, licensing deals and negotiations
  • 260+ worldwide Genomics focused healthcare licensing news of companies across North America (56%), Europe (22%), Asia (14%)
  • Small-mid-large cap companies covered - LargeCap (12.5%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered - Pharmaceuticals (13%), Biotech (42%), Healthcare Services (33%), Medical Devices (9%)
  • 14 medicine groups studied - Oncology (34%), Genetics (18%), Neurology (9%)
  • 8+ variables analyzed

User benefits:

  • Immediate access to current global licensing trends for Genomics
  • Succinct summaries of licensing deals and negotiations held worldwide
  • Quick to-the-point analytical references
  • In-depth updates on the wider perspective of Genomics
  • Directions to the emerging business prospects

Key analysis in the report:

  • Leading countries in Genomics focused licensing
  • Most active healthcare sub-sectors in Genomics focused licensing
  • Distribution of Genomics focused licensing deals among market cap groups
  • Comparisons of different medicine groups in Genomics focused licensing
  • Companies currently engaging the most in Genomics focused licensing
  • Dynamics of varied licensing payments arrangements worldwide

Report useful to:

  • Genomics focused healthcare companies seeking licensing opportunities
  • Genomics focused healthcare companies seeking a new market base
  • Executives of healthcare companies negotiating to license for Genomics
  • Investors analyzing varied kinds of transaction options for Genomics focused licensing

Key Topics Covered:

Introduction

Research Design

Chapter 1: Analysis of healthcare inventions with focus on Genomics licensed during the past 8 months

1.1 Number of licensing deals with a focus on Genomics

1.2 Countries with most licensing deals with a focus on Genomics

1.3 Healthcare sub-sectors with most licensing deals with a focus on Genomics

1.4 Market capitalization groups with most licensing deals with a focus on Genomics

1.5 Medicine groups with most licensing deals with a focus on Genomics

1.6 Leading companies with most licensing deals with a focus on Genomics

1.7 Licensing payment arrangements most followed in licensing deals with a focus on Genomics

Chapter 2: Key licensing deals with a focus on Genomics during the past 8 months - By type of licensing deal

Chapter 3: Global healthcare inventions with focus on Genomics licensed during the past 8 months - By region and company name

Chapter 4: Summary and conclusions

Appendices

Appendix 1 List of companies/institutes covered

a) By region, country and company name

b) By sub-industry, country and company name

c) By market capitalization group, country and company name

d) By medicine group, country and company name

e) By terms of payment, country and company name

Appendix 2 List of non-listed companies covered - By country and company name

Appendix 3 List of not-for-profit institutes covered - By country and institute name

For more information about this report visit https://www.researchandmarkets.com/r/e4xf5p

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900